期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Multi-optimizationofasphericalmechanismforminimallyinvasivesurgery 被引量:2
1
作者 niu guo-jun PAN Bo +2 位作者 ZHANG Fu-hai FENG Hai-bo FU Yi-li 《Journal of Central South University》 SCIE EI CAS CSCD 2017年第6期1406-1417,共12页
In order to obtain the remote center motion(RCM) mechanism with better performance indexes and avoid the collision of multi-manipulators in minimally invasive surgery(MIS), a novel multi-objective optimization model w... In order to obtain the remote center motion(RCM) mechanism with better performance indexes and avoid the collision of multi-manipulators in minimally invasive surgery(MIS), a novel multi-objective optimization model was presented. There were two optimization objectives: a global kinematic performance index and a comprehensive stiffness index. Other indexes to characterize the design requirements such as collision probability, workspace, mechanism parameter, mass, and wall thickness were considered as constraints. Angles between two adjacent joints and cross-section dimensions of links were chosen as the design variables. The non-dominated sorting genetic algorithm II(NSGA-II) was adopted to solve the complex multi-objective optimization problem. Then, a 3-degree of freedom(DoF) MIS robotic prototype based on optimization results has been built up. The experiments to test the spatial position change of the remote center point and to test the absolute position accuracy and repetitive position accuracy of the MIS robot were achieved, and the experimental results meet the requirements of MIS. 展开更多
关键词 MINIMALLY INVASIVE SURGERY medical robot multi-objective optimization remote centre motion
下载PDF
Synthesis and Characterization of Pyrazoleanthrone Derivatives as Aurora A Kinase Inhibitors
2
作者 SUN Xiao-xiao SUN Tao +7 位作者 WANG Tai-yi ZHANG Yan LIU Hui-juan WANG Quan niu guo-jun LIU Wei ZHOU Hong-gang YANG Cheng 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2013年第6期1098-1103,共6页
Aurora A is a cell cycle kinase linked to cancer. For the purpose of finding biologically active of novel compounds and providing new ideas for drug-design, we performed virtual screening in commercially available dat... Aurora A is a cell cycle kinase linked to cancer. For the purpose of finding biologically active of novel compounds and providing new ideas for drug-design, we performed virtual screening in commercially available databases and got pyrazoleanthrone with promising inhibitory activity against Aurora A. Optimization of solvent accessible C7 position of pyrazoleanthrone made us get thirteen target compounds. These pyrazoleanthrone derivatives were evaluated by Aurora A inhibition assays in vitro. The results show that some target compounds could inhibit Aurora A kinase. Meanwhile, these title compounds were tested in vitro against hepatocellular carcinoma(HepG2) cells by the 3'-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) method, showing that most of them had inhibitory potency. The inhibition rate of compound 6h was about 80% against HepG2 cells, and the 1C50 value was 17.4 μmol/L, which would be considered for further study. 展开更多
关键词 Pyrazoleanthrone Aurora-A kinase INHIBITOR Biological activity
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部